GLRX and Parkinson disease: Furthermore, analyses of qRT-PCR and Western blotting exhibited that the mRNA and protein expressions of GLRX in the tissues of patients with PD were decreased to respectively 0.63 ± 0.15-fold and 0.69 ± 0.18-fold (p < 0.05, vs the control group; Fig. 1B,C).